Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lipofundin MCT
DRUG
2 trials
Sponsors
B. Braun Melsungen AG
Conditions
GI Cancer
Malnutrition
Phase 3
Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery
Completed
NCT00798447
B. Braun Melsungen AG
GI Cancer
Start: 2008-11-30
End: 2010-10-31
Target: 100
Updated: 2011-06-09
Phase 4
Safety and Efficacy of Longterm HPN With Two Lipid Emulsions
Completed
NCT00530738
B. Braun Melsungen AG
Malnutrition
Start: 2007-09-30
End: 2014-01-31
Updated: 2014-07-18
Related Papers
Efficacy of a long-term home parenteral nutrition regimen containing fish oil-derived n-3 polyunsaturated fatty acids: a single-centre, randomized, double blind study.
2018-11-30
8 citations
Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients.
2015-01-21
38 citations